biote (BTMD) Competitors $3.37 +0.04 (+1.20%) As of 11:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BTMD vs. AVXL, ABCL, DAWN, CVAC, QURE, PRAX, IMNM, BCAX, REPL, and NUVBShould you be buying biote stock or one of its competitors? The main competitors of biote include Anavex Life Sciences (AVXL), AbCellera Biologics (ABCL), Day One Biopharmaceuticals (DAWN), CureVac (CVAC), uniQure (QURE), Praxis Precision Medicines (PRAX), Immunome (IMNM), Bicara Therapeutics (BCAX), Replimune Group (REPL), and Nuvation Bio (NUVB). These companies are all part of the "pharmaceutical products" industry. biote vs. Anavex Life Sciences AbCellera Biologics Day One Biopharmaceuticals CureVac uniQure Praxis Precision Medicines Immunome Bicara Therapeutics Replimune Group Nuvation Bio Anavex Life Sciences (NASDAQ:AVXL) and biote (NASDAQ:BTMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends. Is AVXL or BTMD more profitable? biote has a net margin of 5.20% compared to Anavex Life Sciences' net margin of 0.00%. biote's return on equity of -32.41% beat Anavex Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Anavex Life SciencesN/A -37.50% -34.08% biote 5.20%-32.41%22.26% Does the MarketBeat Community favor AVXL or BTMD? Anavex Life Sciences received 427 more outperform votes than biote when rated by MarketBeat users. However, 100.00% of users gave biote an outperform vote while only 74.92% of users gave Anavex Life Sciences an outperform vote. CompanyUnderperformOutperformAnavex Life SciencesOutperform Votes44274.92% Underperform Votes14825.08% bioteOutperform Votes15100.00% Underperform VotesNo Votes Which has more volatility and risk, AVXL or BTMD? Anavex Life Sciences has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, biote has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Do analysts recommend AVXL or BTMD? Anavex Life Sciences currently has a consensus target price of $44.00, indicating a potential upside of 372.36%. biote has a consensus target price of $8.00, indicating a potential upside of 137.39%. Given Anavex Life Sciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Anavex Life Sciences is more favorable than biote.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33biote 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation & earnings, AVXL or BTMD? biote has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnavex Life SciencesN/AN/A-$43M-$0.55-16.94biote$197.19M0.93$3.32M$0.1818.72 Do institutionals & insiders have more ownership in AVXL or BTMD? 31.5% of Anavex Life Sciences shares are held by institutional investors. Comparatively, 21.7% of biote shares are held by institutional investors. 11.0% of Anavex Life Sciences shares are held by company insiders. Comparatively, 24.0% of biote shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to AVXL or BTMD? In the previous week, Anavex Life Sciences had 5 more articles in the media than biote. MarketBeat recorded 6 mentions for Anavex Life Sciences and 1 mentions for biote. biote's average media sentiment score of 1.26 beat Anavex Life Sciences' score of 1.19 indicating that biote is being referred to more favorably in the news media. Company Overall Sentiment Anavex Life Sciences Positive biote Positive Summarybiote beats Anavex Life Sciences on 11 of the 18 factors compared between the two stocks. Get biote News Delivered to You Automatically Sign up to receive the latest news and ratings for BTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTMD vs. The Competition Export to ExcelMetricbioteMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$184.92M$1.23B$5.53B$7.99BDividend YieldN/AN/A5.11%4.23%P/E Ratio13.0011.0422.6518.64Price / Sales0.9310.23401.98103.80Price / Cash9.6010.4038.1834.62Price / Book-5.811.456.754.30Net Income$3.32M-$56.07M$3.22B$248.44M7 Day Performance-2.32%4.34%1.66%1.81%1 Month Performance-7.16%24.10%4.17%4.40%1 Year Performance-40.35%-37.10%16.17%5.97% biote Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTMDbiote3.7422 of 5 stars$3.37+1.2%$8.00+137.4%-39.6%$184.92M$197.19M13.00194Upcoming EarningsPositive NewsAVXLAnavex Life Sciences3.8428 of 5 stars$8.76-2.1%$44.00+402.3%+160.3%$745.16MN/A-15.9340Upcoming EarningsNews CoveragePositive NewsABCLAbCellera Biologics2.5959 of 5 stars$2.45+1.2%$7.50+206.1%-31.0%$730.07M$28.83M-4.02500Upcoming EarningsGap DownDAWNDay One Biopharmaceuticals2.4766 of 5 stars$7.14+4.4%$32.29+352.2%-54.5%$723.67M$131.16M-6.9360Upcoming EarningsNews CoverageCVACCureVac3.9582 of 5 stars$3.21+2.9%$10.00+211.5%+40.9%$720.13M$535.18M5.84880Analyst ForecastQUREuniQure2.5691 of 5 stars$13.29+2.2%$38.80+191.9%+234.7%$718.68M$27.12M-2.68500Upcoming EarningsShort Interest ↑Analyst RevisionHigh Trading VolumePRAXPraxis Precision Medicines3.4823 of 5 stars$35.34+4.6%$123.33+249.0%-31.4%$712.56M$8.55M-3.43110Analyst ForecastPositive NewsIMNMImmunome2.5945 of 5 stars$8.00+1.1%$25.14+214.3%-37.5%$695.61M$9.04M-0.9940Positive NewsBCAXBicara TherapeuticsN/A$12.65+4.0%$32.43+156.4%N/A$689.72MN/A0.0032Analyst RevisionNews CoveragePositive NewsGap DownREPLReplimune Group4.1946 of 5 stars$8.77+9.8%$19.43+121.5%+54.0%$675.42MN/A-2.86210Positive NewsNUVBNuvation Bio3.5715 of 5 stars$1.99+0.8%$8.75+340.8%-25.1%$672.28M$7.87M-0.9160Positive News Related Companies and Tools Related Companies Anavex Life Sciences Alternatives AbCellera Biologics Alternatives Day One Biopharmaceuticals Alternatives CureVac Alternatives uniQure Alternatives Praxis Precision Medicines Alternatives Immunome Alternatives Bicara Therapeutics Alternatives Replimune Group Alternatives Nuvation Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BTMD Stock Free BTMD Stock Alerts